Navigation Links
Haemonetics Reports 2nd Quarter Fiscal 2014 Revenue Up 8%; Adjusted Operating Margin Up 260 Basis Points; and $0.66 Adjusted EPS Up 24%
Date:10/28/2013

formation and other costs$18,872$23,667Six Months Ended9/28/20139/29/2012Manufacturing network optimization

$

27,893$

—Commercial excellence initiatives

4,165—Productivity and operational initiatives

1,1132,924Accelerated depreciation, asset write-down and other

4,458—Whole blood acquisition and integration

10,23427,181In process research and development

3,976—Market-based stock compensation

550—Total restructuring, transformation and other costs$52,389$30,105Deal Amortization(Unaudited data in thousands) 

GAAP results include the following item which is excluded from adjusted results.Three Months Ended9/28/20139/29/2012Deal amortization$

6,893$

6,142Six Months Ended9/28/20139/29/2012Deal amortization$

13,612$

8,806Beginning in fiscal 2014, we are reporting adjusted earnings before deal amortization. Fiscal 2013 has been adjusted to conform with this presentation. 

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
gerry.gould@haemonetics.com
Alt. (781) 356-9613

 


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
2. Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
3. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
4. Haemonetics Announces Next Steps in Manufacturing Transformation
5. Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference
6. Haemonetics Completes Hemerus Medical, LLC Acquisition
7. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
8. Haemonetics Sets Date for Investor/Analyst Meeting
9. Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
10. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
11. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 Actavis plc (NYSE: ... offering of $21 billion aggregate principal amount of senior ... offering to be issued by its indirect wholly-owned subsidiary, ... other subsidiaries (the "Notes"), as follows: Logo ... Notes* , $500,000,000 , Due 2016 , ...
(Date:3/3/2015)... 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... hospital acute care and gastroenterology, today announced achievement ... include top-line results from the Company,s Hepatoren Phase ... Application (sNDA) with pediatric data for Caldolor and ... II clinical trial. "The sNDA for ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tbjpmj/blister_packaging ) ... Market in the US 2015-2019" report to their ... the US to grow at a CAGR of 6.11% ... form of high-visibility packaging that uses pre-formed plastic packs ... a base layer, made either of plastic or aluminum, ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 3Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 4Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 5United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2
... Oct. 31, 2011 Rock Creek Pharmaceuticals, a wholly owned ... today announced the second presentation of research findings related to ... a Tobacco Alkaloid, Ameliorates Disease in a Mouse Model of ... meeting of the American Thyroid Association in Indian Wells, CA ...
... SYDNEY, Oct. 31, 2011  To successfully irradiate a moving lung ... the tumor from moving or a means to compensate for ... Hospital Cancer Centre (Randwick, New South Wales) chose the second ... for the first time to treat a 75-year-old male patient ...
Cached Medicine Technology:Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 2Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 3Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 4Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology 2Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology 3
(Date:3/4/2015)... March 04, 2015 Information Innovators ... John Dvorak has joined the company as Chief ... the technology focus for the company, including customer-centric strategies ... brings 20 years of experience as a technology executive ... diverse roles at the FBI including oversight of enterprise ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 According to ... millions of people in the U.S. suffer from gastroesophageal ... Medications are commonly prescribed to control acid production, but ... procedures can overly correct the problem and lead to ... Opportunity, GERD occurs when the lower esophageal sphincter does ...
(Date:3/4/2015)... Ohio (PRWEB) March 04, 2015 Staff ... an IED explosion in Iraq, tells you about the ... received some free Chiropractic care from the Patriot Project ... Therapy. , This is what Harris said in a ... I have clarity, I feel more calm, I'm sleeping ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Today Visiopharm ... Dako , has joined the Visiopharm Board of ... at a time when we are positioned to become ... pathology for cancer diagnostics and research. , ... in the development and validation of ONCOtopix™ Dx, a ...
(Date:3/4/2015)... 2015 Nike Swim Camps offer outstanding ... mission is to stimulate a love of swimming in ... provide campers the opportunity to train with some of ... Merrion, Vice President of US Sports Camps. “Our program ... to build confidence and improve their technique.” , Nike ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2
... in utero stem cell treatment could lead to a ... a range of other disabling,conditions, according to a maternal-fetal ... , Action Medical Research has announced the outcomes of ... by Professor Nicholas Fisk, that could lead to a ...
... in the human genome that originated from ancient viral ... are even essential for a healthy pregnancy, according to ... , Retrovirus infections represent the most intimate host-pathogen relationship. ... the DNA of the host cell, resulting in an ...
... improves enterprise security, reduces risk and ... ... Inc., a global,provider of integrated security, risk and audit management ... Kingdom,s National,Health Service (NHS) has selected its flagship SecureVue(R) platform ...
... Home care services franchise jumps to #187 in Entrepreneur Magazine,s 29th ... ... Homewatch CareGivers has been ranked,#187 in Entrepreneur Magazine,s 29th Annual Franchise ... by 40 places,over 2007, and retained its rankings among top industry ...
... ABBOTT PARK, Ill., Jan. 29 Abbott will,present ... Device Conference on Tuesday, Feb. 5, 2008. Thomas ... officer, will make a,formal presentation on the company ... audio webcast of the presentation will be accessible ...
... a New Way to Shop for Baby Products, With Information, on ... ... Well, NORCROSS, Georgia, ... The,comprehensive website offers new parents an opportunity to save time and,money with ...
Cached Medicine News:Health News:Stem cell treatment for brittle bones in the womb 2Health News:The North Western Deanery of UK's National Health Service Selects eIQnetworks' SecureVue for Comprehensive IT Assurance 2Health News:The North Western Deanery of UK's National Health Service Selects eIQnetworks' SecureVue for Comprehensive IT Assurance 3Health News:Homewatch CareGivers Improves in Entrepreneur Magazine Rankings 2Health News:BabySupply.Info Announces Launch of Website for New Parents 2
LB Agar plates with 0.1mM EDTA....
1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride, 7.5% Glycerol....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Inoculum Broth...
Medicine Products: